Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitsuhiro Takeno

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Modern Rheumatology|November 22, 2019
Positioning of apremilast in treatment of Behçet's diseaseMitsuhiro Takeno
Current Opinion in Rheumatology|October 25, 2021
The association of Behçet's syndrome with HLA-B51 as understood in 2021Mitsuhiro Takeno
Current Opinion in Immunology|January 14, 2026
A critical look at animal and cellular models in autoinflammatory diseasesYohei Kirino, Mitsuhiro Takeno
Therapeutics and Clinical Risk Management|May 1, 2015
Adalimumab in the management of Behçet's diseaseAtsuhisa Ueda, Mitsuhiro Takeno, Yoshiaki Ishigatsubo
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 24, 2007
[Tuberculosis associated with anti-TNF therapy]Mitsuhiro Takeno, Shuji Murakami, Yoshiaki Ishigatsubo
Journal of Gastroenterology|December 6, 2024
Behçet's disease: incidence, prevalence, and real-word data on the use of biologic agents in JapanTadakazu Hisamatsu, Makoto Naganuma, Philippe Pinton, et al.
Experimental Hematology|December 17, 2002
Flk1+ cells derived from mouse embryonic stem cells reconstitute hematopoiesis in vivo in SCID miceTsukasa Miyagi, Mitsuhiro Takeno, Hiroko Nagafuchi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2002
Txk, a member of nonreceptor tyrosine kinase of Tec family, acts as a Th1 cell-specific transcription factor and regulates IFN-gamma gene transcriptionYuko Takeba, Hiroko Nagafuchi, Mitsuhiro Takeno, et al.
Lung Cancer (Amsterdam, Netherlands)|April 21, 2009
Inhibition of heme oxygenase-1 with an epidermal growth factor receptor inhibitor and cisplatin decreases proliferation of lung cancer A549 cellsHideyo Kuroda, Mitsuhiro Takeno, Shuji Murakami, et al.
Journal of Scleroderma and Related Disorders|October 10, 2022
Severe digital ischemia as an unrecognized manifestation in patients with antisynthetase autoantibodies: Case series and systematic literature reviewAkira Yoshida, Takahisa Gono, Yuka Okazaki, et al.
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Modern Rheumatology|November 22, 2019
Positioning of apremilast in treatment of Behçet's diseaseMitsuhiro Takeno
Current Opinion in Rheumatology|October 25, 2021
The association of Behçet's syndrome with HLA-B51 as understood in 2021Mitsuhiro Takeno
Current Opinion in Immunology|January 14, 2026
A critical look at animal and cellular models in autoinflammatory diseasesYohei Kirino, Mitsuhiro Takeno
Therapeutics and Clinical Risk Management|May 1, 2015
Adalimumab in the management of Behçet's diseaseAtsuhisa Ueda, Mitsuhiro Takeno, Yoshiaki Ishigatsubo
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 24, 2007
[Tuberculosis associated with anti-TNF therapy]Mitsuhiro Takeno, Shuji Murakami, Yoshiaki Ishigatsubo
Journal of Gastroenterology|December 6, 2024
Behçet's disease: incidence, prevalence, and real-word data on the use of biologic agents in JapanTadakazu Hisamatsu, Makoto Naganuma, Philippe Pinton, et al.
Experimental Hematology|December 17, 2002
Flk1+ cells derived from mouse embryonic stem cells reconstitute hematopoiesis in vivo in SCID miceTsukasa Miyagi, Mitsuhiro Takeno, Hiroko Nagafuchi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2002
Txk, a member of nonreceptor tyrosine kinase of Tec family, acts as a Th1 cell-specific transcription factor and regulates IFN-gamma gene transcriptionYuko Takeba, Hiroko Nagafuchi, Mitsuhiro Takeno, et al.
Lung Cancer (Amsterdam, Netherlands)|April 21, 2009
Inhibition of heme oxygenase-1 with an epidermal growth factor receptor inhibitor and cisplatin decreases proliferation of lung cancer A549 cellsHideyo Kuroda, Mitsuhiro Takeno, Shuji Murakami, et al.
Journal of Scleroderma and Related Disorders|October 10, 2022
Severe digital ischemia as an unrecognized manifestation in patients with antisynthetase autoantibodies: Case series and systematic literature reviewAkira Yoshida, Takahisa Gono, Yuka Okazaki, et al.
Pageof 12